[Drug surveillance. Monitoring the collateral effects of drugs in the post-marketing phase: cimetidine. I].
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002927:Cimetidine / Q000009:adverse effects*; D004700:Endocrine System Diseases / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008099:Liver / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced; D010195:Pancreatitis / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing; D014570:Urologic Diseases / Q000139:chemically induced
D002927:Cimetidine
Farmaco-vigilanza. Monitoraggio degli effetti collaterali dei farmaci in fase post-marketing: la cimetidina. Parte I.